Combating Multidrug-resistant Gram-negative Bacteria in Africa Through Diagnostic and Antimicrobial Stewardship

计划入组 1,320 人 · 首次发布于 2026 年 9 月 15 日

Use of New Antibiotics in Sweden

计划入组 41 人 · 首次发布于 2021 年 9 月 17 日

Real-world Multicentre Study of AZtreonam-AVIbactam Treatment With Infections or Suspected Infections Caused by Multidrug-resistant Gram-negative Bacteria

计划入组 100 人 · 首次发布于 2025 年 9 月 16 日

LpxC inhibitors (Gram negative bacteria infection)

Gram - ve bacteria(Orthogon Therapeutics)

Gram-negative infection therapeutics (Shionogi)

Acurx Pharmaceuticals

United States

Arvinas

United States

Cardiff Oncology

United States

Basilea Pharmaceutica Acquires Global Rights to Phase 3-Ready Oral Antibiotic for Drug-Resistant UTIs

Centauri Therapeutics Secures £6M from AMR Action Fund to Advance Novel Antibiotic CTX-187 Through Phase I Trials

FDA Grants QIDP Status to Venus Remedies' Novel Antibiotic VRP-034 for Bloodstream Infections